India’s Expanding Vaccines Market Offers Promise To Global And Local Drug Firms (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Several companies are gearing up to go full throttle into the Indian vaccines market in programs that go beyond pushing products and seek to build public health awareness on a larger scale. GSK, Sanofi, Merck, Novartis, and Pfizer Inc. are in the fray with local players Serum Institute of India, Bharat Biotech International, and Panacea Biotec.